SCHEMBL13634107

SCHEMBL13634107

Cc1cnc2nc1Nc1cccc(c1)C(=O)Nc1cccc(c1)N2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 11/20 0.56
JAK1 P23458 8/20 0.56
JAK3 P52333 8/20 0.56
STK26 Q9P289 2/20 0.42
STK24 Q9Y6E0 2/20 0.42
CDK2 P24941 4/20 0.36
CCNA2 P20248 3/20 0.36
FLT3 P36888 3/20 0.36
CCNA1 P78396 3/20 0.36
PDPK1 O15530 1/20 0.36
GAK O14976 4/20 0.36
EPHA2 P29317 4/20 0.36
CDK1 P06493 1/20 0.36
KDR P35968 1/20 0.36
ALK Q9UM73 5/20 0.35
STK4 Q13043 1/20 0.35
STK3 Q13188 1/20 0.35
TYK2 P29597 6/20 0.34
FGFR1 P11362 3/20 0.34
FLT1 P17948 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1074976 0.84 JAK2 (0.72) JAK2JAK1JAK3STK26STK24
SCHEMBL1075083 0.84 JAK2 (0.72) JAK2JAK1JAK3STK26STK24
Hydrochloric Acid SCHEMBL1075617 0.83 JAK2 (0.71) JAK2JAK1JAK3STK26STK24
Hydrochloric Acid SCHEMBL1075124 0.83 JAK2 (0.71) JAK2JAK1JAK3STK26STK24
SCHEMBL4358458 0.79 JAK2 (0.40) JAK2JAK1JAK3STK26STK24
SCHEMBL4354832 0.78 ALK (0.55) JAK2JAK1JAK3STK26STK24
SCHEMBL2519410 0.72 JAK2 (1.00) JAK2JAK1JAK3STK26STK24
Trifluoroacetic Acid SCHEMBL1075059 0.70 PTK2 (0.40) JAK2JAK1JAK3STK26STK24
Nitrogen SCHEMBL7672060 0.70 JAK2 (0.43) JAK2JAK1JAK3
Trifluoroacetic Acid SCHEMBL1076667 0.69 ALK (0.47) JAK2JAK1JAK3STK26STK24

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286778-A1 MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS INCYTE CORPORATION (US) 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286778-A1 MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS JAK2, JAK1, ALK JAK2 1/4885JAK1 2/4885JAK3 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.